Lantus Rebating Saga Underscores Payer Willingness To Confront Market Leaders
Executive Summary
Pricing pressure on Sanofi’s blockbuster insulin Lantus recalls GlaxoSmithKline’s recent struggles with payers over coverage for its best-selling asthma drug, Advair Diskus.